Mick Peake

Type: Person
Name: Mick Peake
First reported Apr 04 2014 - Updated Apr 04 2014 - 2 reports

NICE U-turn on Roche's Tarceva

The National Institute for Health and Care Excellence (NICE) has issued revised draft guidance reversing its decision to restrict access to Roche’s Tarceva (erlotinib) in patients with second-line non-small cell lung cancer (NSCLC). In 2008, NICE recommended ... [Published Pharma Times - Apr 04 2014]
First reported Jan 24 2014 - Updated Jan 24 2014 - 1 reports

Too many needless deaths because elderly cancer sufferers are 'written off'

Elderly cancer sufferers miss out on life-saving treatment because doctors 'write them off,' charity says More than 14,000 lives a year could be saved if elderly cancer patients were not "written-off"as too old for treatment, a leading charity has sa ... [Published Telegraph - Jan 24 2014]

More Content

All (5) | News (5) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
NICE U-turn on Roche cancer drug [Published Pharmafocus - Apr 04 2014]
UK’s NICE reverses negative decision on Roche’s... [Published Pharma Letter - Apr 04 2014]
NICE U-turn on Roche's Tarceva [Published Pharma Times - Apr 04 2014]
NICE reverses decision to restrict Tarceva access [Published PMLive - Apr 04 2014]
Too many needless deaths because elderly cancer... [Published Telegraph - Jan 24 2014]
Contact Us

Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.